Author: Christelle Kerouedan

DIVERSITY, EQUITY & INCLUSION: Views from Leadership


“For us to drive innovation that addresses the diverse healthcare needs of our global society, we need a diverse team…”

In the next interview in our Diversity, Equity & Inclusion Leadership series, we spoke to Tomoko Adachi, General Manager of Global HR and HR Business Partner for the Cardiac and Vascular Company at Terumo Corporation. Tomoko shares her insights in good D, E & I practice from her recent experience in medtech and compares this with what she has seen in the tech world, drawing on her 29-year tenure with Sony before Terumo.

Coulter Partners announces two additional appointments in Italy

Coulter Partners announces two additional appointments to its new Milan office. Giulia Bacis joins as Senior Consultant and Anna Senzacqua as Consultant. Together with Francesca Lazzarin, Executive Director, Yasemin Holland, Senior Research Associate and Giuliana Milioto, Research Associate, they make up the Italian team who will enrich the firm’s offering to companies growing from Italian headquarters and those expanding into Italy.

Coulter Partners expands its global team with key appointments and a new office in Italy

Coulter Partners announces the opening of its new office in Milan and two additional key appointments. Francesca Lazzarin joins as Executive Director and Giuliana Milioto as Research Associate. We will be announcing two further appointments next week. They will all work across Europe with a particular focus on the Italian market, alongside recently appointed Yasemin Holland, Senior Research Associate. These new colleagues will particularly enrich the firm’s offering to companies growing from Italian headquarters and those expanding into Italy.

HUMAN STRATEGY SERIES


“I like the excitement of not knowing what’s going to happen and I think I thrive on it.”

For the first interview in our Human Strategy Series, the team recently spoke with Dr Jackie Ameri, CEO of Pancryos, who benefited from our Leadership Assessment service as part of the partnership between Coulter Partners and the BioInnovation Institute (BII). Jackie discusses her early career, her decision to join the BII and highlights the benefits of being part of the BII Creation House Program.

Coulter Partners places new Chief Scientific and Chief People Officers at Totus Medicines, supporting the drug discovery company’s senior leadership expansion


Coulter Partners recently partnered with Totus Medicines, the drug discovery company using breakthrough chemical biology to make the entire human genome druggable, and was pleased to secure the appointment of Dr. Wei Chen and Daisy Chhokar as the company’s first Chief Scientific Officer (CSO) and Chief People Officer (CPO), respectively.

DIVERSITY, EQUITY & INCLUSION: Views from Leadership

“…I believe that specifically in healthcare, diversity is hugely important. The most critical value of diversity in healthcare is to improve patient outcomes…”

As part of our Diversity, Equity & Inclusion Leadership series, we spoke to Corinne Le Goff, until recently Chief Commercial Officer at Moderna, a pioneer in mRNA therapeutics and developer of the second mRNA COVID-19 vaccine to be approved. Corinne brings over 30 years’ experience in pharmaceuticals, having held senior strategic and commercial leadership roles at Amgen, Roche, Merck AG and Sanofi, mostly in the US, but also in France and Switzerland.